SELLAS Life Sciences Group Inc (SLS)
1.25
-0.25
(-16.67%)
USD |
NASDAQ |
Jun 17, 16:00
1.25
0.00 (0.00%)
After-Hours: 20:00
SELLAS Life Sciences Group Market Cap: 72.19M for June 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| June 14, 2024 | 86.63M |
| June 13, 2024 | 83.74M |
| June 12, 2024 | 83.74M |
| June 11, 2024 | 82.01M |
| June 10, 2024 | 81.43M |
| June 07, 2024 | 83.74M |
| June 06, 2024 | 84.90M |
| June 05, 2024 | 85.48M |
| June 04, 2024 | 81.43M |
| June 03, 2024 | 82.01M |
| May 31, 2024 | 81.43M |
| May 30, 2024 | 80.86M |
| May 29, 2024 | 77.97M |
| May 28, 2024 | 79.70M |
| May 24, 2024 | 80.86M |
| May 23, 2024 | 77.97M |
| May 22, 2024 | 82.59M |
| May 21, 2024 | 82.01M |
| May 20, 2024 | 85.48M |
| May 17, 2024 | 84.32M |
| May 16, 2024 | 84.90M |
| May 15, 2024 | 84.90M |
| May 14, 2024 | 79.12M |
| May 13, 2024 | 79.12M |
| May 10, 2024 | 78.26M |
| Date | Value |
|---|---|
| May 09, 2024 | 74.50M |
| May 08, 2024 | 73.93M |
| May 07, 2024 | 76.24M |
| May 06, 2024 | 74.50M |
| May 03, 2024 | 76.81M |
| May 02, 2024 | 77.97M |
| May 01, 2024 | 73.93M |
| April 30, 2024 | 71.62M |
| April 29, 2024 | 69.88M |
| April 26, 2024 | 84.32M |
| April 25, 2024 | 87.79M |
| April 24, 2024 | 86.65M |
| April 23, 2024 | 91.72M |
| April 22, 2024 | 86.65M |
| April 19, 2024 | 86.65M |
| April 18, 2024 | 85.53M |
| April 17, 2024 | 79.34M |
| April 16, 2024 | 76.52M |
| April 15, 2024 | 74.84M |
| April 12, 2024 | 75.40M |
| April 11, 2024 | 78.77M |
| April 10, 2024 | 78.21M |
| April 09, 2024 | 78.77M |
| April 08, 2024 | 81.31M |
| April 05, 2024 | 75.40M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
5.799M
Minimum
Jun 28 2019
211.83M
Maximum
Jun 28 2021
62.17M
Average
47.03M
Median
May 09 2022
Market Cap Benchmarks
| Geron Corp | 2.776B |
| Immuneering Corp | 45.37M |
| Protagonist Therapeutics Inc | 1.905B |
| Akebia Therapeutics Inc | 222.17M |
| Moderna Inc | 52.84B |
Market Cap Related Metrics
| PEG Ratio | -0.0156 |
| Price to Book Value | 7.455 |
| Price | 1.25 |
| Earnings Yield | -88.00% |
| PEGY Ratio | -0.0156 |